Loading

research

  • by Erik Altieri, NORML Communications Director April 4, 2013

    For the first time since they began polling the question four decades ago, Pew Research Polling has released new survey data that reveals 52% of Americans want marijuana to be legalized. Only 45% were opposed.

    This support is spread across demographics. The Baby Boomers (50%), Generation X (54%), and Millenials (65%) all have majority support for legalization. The only age demographic that remains opposed is the Silent Generation, those born before 1942, though support in this age group has also significantly increased. 32% of this age group now support legalization, up from 17% in 2002.

    According to this polling data, most Americans have also tried marijuana personally. 48% of respondents answered affirmatively when asked if they consume marijuana, up from 38% about a decade ago.

    Not only are Americans becoming more supportive of legalization, but there has been a dramatic change in how Americans view marijuana use. In 2006, Pew Research found that 50% of Americans believed smoking marijuana was “morally wrong” and only 35% did not think it was a moral issue. Today these numbers have completely flipped, 50% of Americans responded in this latest survey that using marijuana is not a moral issue and only 32% stated it was morally wrong.

    60% of Americans across all political orientations also believe the federal government should not enforce federal marijuana laws in states that legalize it. 57% of Republicans, 59% of Democrats, and 64% of Independents believe the federal government should leave states like Washington and Colorado alone.

    You can view the full results of this survey here.

  • by Paul Armentano, NORML Deputy Director July 31, 2012

    As I wrote last week in an op/ed for The Sacramento Bee, when it comes to the federal government’s policy on marijuana, not so much.

    Viewpoints: Science supporting medicinal pot is clear
    via The Sacramento Bee

    A dozen years ago, California lawmakers did something extraordinary. They authorized investigators throughout California to conduct a series of FDA-approved, gold standard trials to assess whether cannabis is safe and effective as a medicine.

    In all, researchers conducted more than a dozen clinical studies examining whether cannabis could meet objective standards of safety and therapeutic efficacy. For example, investigators at the University of California, San Francisco, assessed whether vaporizing cannabis could rapidly and consistently deliver the plant’s active ingredients to patients in a manner that is far safer than smoking. It could. At UC San Diego, clinicians examined whether inhaling cannabis posed potential harms to the immune system, particularly in subjects suffering from immune-compromised conditions like HIV. It didn’t. And at universities throughout the state, investigators studied whether marijuana provided statistically significant relief in a number of hard-to-treat conditions, such as multiple sclerosis and neuropathic (nerve) pain. Cannabis did so – consistently.

    … Nonetheless, policymakers – particularly those in Washington – have responded to these most recent scientific findings with no more than a collective yawn. Despite pledging to let “science and the scientific process … inform and guide decisions of my administration,” neither President Barack Obama nor Congress have taken any steps to amend federal law or federal policy to reflect the scientific reality that marijuana possesses well-established therapeutic value. In fact, this administration has taken just the opposite approach.

    In 2011, the Obama administration quashed out-of-hand an administrative petition that sought federal hearings regarding the present classification of cannabis as a substance with “no currently accepted medical use in treatment in the United States.” In its rejection, the administration alleged, “The drug’s chemistry is not known and reproducible; there are no adequate safety studies; there are no adequate and well-controlled studies proving efficacy; the drug is not accepted by qualified experts; and the scientific evidence is not widely available.”

    Yet, the findings from California’s 12-year-old study program show that each of these claims is demonstrably false.

    It is long past time to reject the notion that we as a society possess insufficient evidence regarding the safety and efficacy of cannabis. The truth is that we know plenty. Most of all we know that there remains no valid scientific reason to justify the continued targeting, prosecution and incarceration of those Americans who consume cannabis responsibly.

    Read my entire commentary here.

  • by Erik Altieri, NORML Communications Director June 1, 2012

    This Week in Weed

    Click here to subscribe to NORMLtv and receive alerts whenever new content is added.

    The latest installment of “This Week in Weed” is now streaming on NORMLtv.

    This week: A new study shows cannabis use decreases mortality rate in patients with schizophrenia and related ailments and Rhode Island’s Governor signs a bill allowing for “Compassion Centers.”

    YouTube Preview Image

    Also, check out this latest NORML PSA, featuring some great rhyming on the problems of prohibition, submitted to us from artist Will Brennan:
    YouTube Preview Image

    Be sure to tune in to NORMLtv every week to catch up on the latest marijuana news. Subscribe to NORMLtv or follow us on Twitter to be notified as soon as new content is added.

  • by Erik Altieri, NORML Communications Director March 16, 2012

    This Week in Weed

    Click here to subscribe to NORMLtv and receive alerts whenever new content is added.

    The latest installment of “This Week in Weed” is now streaming on NORMLtv.

    This week in weed: new research looks at drinking laws and how they alter cannabis use and New Hampshire takes a step towards marijuana decriminalization.

    YouTube Preview Image

    Be sure to tune in to NORMLtv every week to catch up on the latest marijuana news. Subscribe to NORMLtv or follow us on Twitter to be notified as soon as new content is added.

  • by Erik Altieri, NORML Communications Director March 2, 2012

    This Week in Weed

    Click here to subscribe to NORMLtv and receive alerts whenever new content is added.

    The newest installment of “This Week in Weed” is now streaming on NORMLtv.

    This week in weed: Colorado’s legalization initiative officially qualifies for the November ballot and a new report shows how the federal government stifles research into cannabis’ medicinal applications.

    YouTube Preview Image

    Be sure to tune in to NORMLtv every week to catch up on the latest marijuana news. Subscribe to NORMLtv or follow us on Twitter to be notified as soon as new content is added.

Page 1 of 212